SCHEMBL3246058

SCHEMBL3246058

CC(C)(C)OC(=O)N1CC[C@@H](CCO[Si](C)(C)C(C)(C)C)[C@@H](C(O)CO)C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.37
HPGD P15428 1/20 0.36
TRPV3 Q8NET8 2/20 0.35
NR1H2 P55055 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
MAPT P10636 2/20 0.34
ALDH1A1 P00352 1/20 0.34
FAAH O00519 1/20 0.34
GPR119 Q8TDV5 3/20 0.33
PRMT5 O14744 1/20 0.33
WDR77 Q9BQA1 1/20 0.33
KDM4E B2RXH2 1/20 0.33
THRB P10828 1/20 0.33
PTPN2 P17706 1/20 0.33
PTPN1 P18031 1/20 0.33
PTPN6 P29350 1/20 0.33
EPHX1 P07099 1/20 0.33
USP2 O75604 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3250603 0.80 RECQL (0.39) RECQLHPGDNR1H2MEN1KMT2A
SCHEMBL5304979 0.79 RECQL (0.39) RECQLHPGDNR1H2MEN1KMT2A
SCHEMBL5441281 0.76 ALDH1A1 (0.39) RECQLHPGDMEN1KMT2AMAPT
SCHEMBL3252633 0.75 RECQL (0.38) RECQLHPGDNR1H2MEN1KMT2A
SCHEMBL16096074 0.74 NR1H2 (0.42) RECQLHPGDNR1H2MEN1KMT2A
SCHEMBL16096076 0.74 NR1H2 (0.42) RECQLHPGDNR1H2MEN1KMT2A
SCHEMBL16120910 0.74 NR1H2 (0.42) RECQLHPGDNR1H2MEN1KMT2A
SCHEMBL5454378 0.73 RECQL (0.36) RECQLHPGDMEN1KMT2AMAPT
SCHEMBL5446260 0.73 RECQL (0.34) RECQLHPGDMEN1KMT2AMAPT
SCHEMBL23485811 0.73 RECQL (0.43) RECQLHPGDMEN1KMT2AFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1799674-B1 NEW PIPERIDINE ANTIBIOTICS ACTELION PHARMACEUTICALS LTD (CH) 2010-05-05 EP disclosed
US-20070173532-A1 New Piperidine Antibiotics ACTELION PHARMACEUTICALS LTD. (CH) 2007-07-26 US disclosed
EP-1799674-A1 NEW PIPERIDINE ANTIBIOTICS Actelion Pharmaceuticals Ltd. (CH) 2007-06-27 EP disclosed
WO-2006038172-A1 NEW PIPERIDINE ANTIBIOTICS ACTELION PHARMACEUTICALS LTD (CH) 2006-04-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070173532-A1 New Piperidine Antibiotics OPRM1, SIGMAR1, CBR3 RECQL 2636/4885HPGD 3726/4885TRPV3 2099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.